MAPT and Alzheimer disease: The Aβ42/Aβ40 ratio is considered to be indicative of AD severity and progression, with increased ratios representative of higher neurotoxicity and Tau pathology via induction of Aβ fibril formation (Kumar-Singh et al. 2006; Kuperstein et al. 2010).